[Treatment of rheumatoid arthritis in 2005: prompt, agressive and customized].
Treatment of rheumatoid arthritis in 2005: prompt, aggressive and customized Rheumatoid arthritis can be extremely serious (joint destruction, functional loss, decrease in life expectancy). Fortunately, our therapeutic means have recently progressed enormously (better appreciation of efficacy and ways to use DMARDs combinations and new molecules such as leflunomide and anti-TNFs, understanding of the importance of early adequate and intensive treatments when necessary). Huge progresses have also been performed with regards to evaluation and follow-up strategies (disease activity score--DAS, health assessment questionnaire--HAQ), which allows us to adapt the treatment much better. The goal now can and must be quick and total remission of the disease in all patients thus avoiding as much as possible irreversible joint damages with accompanying morbidities.
Guerne
P-A
PA
Département de médecine, HUG, 1211 Genève 14. pierre-andre-guerne@medecine.unige.ch
Stingelin-Guerne
S
S
D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002985:Clinical Protocols; D006801:Humans